España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
AIM ImmunoTech
AIM
AMEX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.2193
0.00550
2.57%
At close: -
$0.2334
0.01
6.43%
After Hours: 7:56 PM EDT
Get Report
Comment
AIM ImmunoTech (AIM) Forecast
News
Earnings
AIM ImmunoTech (AIM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for AIM ImmunoTech (AMEX:AIM) Stock
AIM ImmunoTech Stock (AMEX: AIM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 15, 2025
AIM ImmunoTech Announces Progress In Ampligen...
Benzinga Newsdesk
Tuesday, December 17, 2024
AIM ImmunoTech Receives Notice That It Is No ...
Benzinga Newsdesk
Thursday, December 12, 2024
Aim ImmunoTech Urges Shareholders To Vote On ...
Benzinga Newsdesk
AIM ImmunoTech Announced It Was Granted Paten...
Benzinga Newsdesk
Tuesday, December 10, 2024
Ascendiant Capital Maintains Buy on AIM Immun...
Benzinga Newsdesk
Thursday, December 05, 2024
ISS Recommends AIM ImmunoTech Shareholders Vo...
Benzinga Newsdesk
Monday, December 02, 2024
Kellner Group Urges Stockholders Of AIM Immun...
Benzinga Newsdesk
AIM ImmunoTech Issues Presentation Detailing ...
Benzinga Newsdesk
Wednesday, November 27, 2024
AIM ImmunoTech Refutes Activist Group's False...
Benzinga Newsdesk
Aim Immunotech Announced Cash Conservation Pl...
Benzinga Newsdesk
Monday, November 25, 2024
AIM ImmunoTech Issues Presentation Detailing ...
Benzinga Newsdesk
Thursday, November 21, 2024
SEC Form 4 Filing Shows AIM ImmunoTech CEO An...
Benzinga Newsdesk
Wednesday, November 20, 2024
AIM ImmunoTech Form4 Filing Shows CEO And Pre...
Benzinga Newsdesk
Tuesday, November 19, 2024
AIM ImmunoTech shares are trading higher afte...
Benzinga Newsdesk
AIM ImmunoTech Announces Publication Of Phase...
Benzinga Newsdesk
Monday, November 18, 2024
Roswell Park's Phase 1 Trial Results For Trip...
Benzinga Newsdesk
Friday, November 15, 2024
AIM ImmunoTech shares are trading higher afte...
Benzinga Newsdesk
AIM ImmunoTech Q3 2024 GAAP EPS $(0.06) Beats...
Benzinga Newsdesk
Earnings Scheduled For November 15, 2024
Benzinga Insights
Thursday, November 14, 2024
Insights into AIM ImmunoTech's Upcoming Earnings
Benzinga Insights
Thursday, November 07, 2024
Exploring AIM ImmunoTech's Earnings Expectations
Benzinga Insights
Monday, November 04, 2024
AIM ImmunoTech Files Definitive Proxy Stateme...
Benzinga Newsdesk
Tuesday, October 22, 2024
Maxim Group Maintains Buy on AIM ImmunoTech, ...
Benzinga Newsdesk
Thursday, October 03, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
AIM ImmunoTech shares are trading higher afte...
Benzinga Newsdesk
AIM ImmunoTech Granted U.S. Patent No. 12,102...
Benzinga Newsdesk
Monday, September 30, 2024
AIM ImmunoTech Announces Pricing Of $1.26M Re...
Benzinga Newsdesk
Thursday, September 19, 2024
AIM ImmunoTech shares are trading higher afte...
Benzinga Newsdesk
AIM ImmunoTech Announces Prelim. Data From Ph...
Benzinga Newsdesk
Wednesday, September 11, 2024
AIM ImmunoTech Announces That Analysis Of AMP...
Benzinga Newsdesk
Tuesday, September 03, 2024
Ascendiant Capital Maintains Buy on AIM Immun...
Benzinga Newsdesk
Tuesday, August 20, 2024
AIM ImmunoTech shares are trading higher afte...
Benzinga Newsdesk
AIM ImmunoTech Announces Print Publication Of...
Benzinga Newsdesk
Friday, August 16, 2024
AIM ImmunoTech Q2 2024 GAAP EPS $(0.03) Beats...
Benzinga Newsdesk
Wednesday, July 24, 2024
AIM ImmunoTech Announces New Pre-Clinical Dat...
Benzinga Newsdesk
Friday, May 31, 2024
ImmunoTech Announces Pricing Of 5,640,958 Sha...
Benzinga Newsdesk
Thursday, May 16, 2024
AIM ImmunoTech Q1 2024 GAAP EPS $(0.12), Inli...
Benzinga Newsdesk
Monday, May 06, 2024
AIM ImmunoTech Completes cGMP Manufacturing O...
Benzinga Newsdesk
Monday, April 29, 2024
AIM ImmunoTech Complete Safety Evaluation Of ...
Benzinga Newsdesk
Wednesday, April 10, 2024
AIM ImmunoTech Announces Top-Line, Protocol-P...
Benzinga Newsdesk
Wednesday, April 03, 2024
AIM ImmunoTech Q4 EPS $(0.26) Misses $(0.15) ...
Benzinga Newsdesk
Tuesday, April 02, 2024
AIM ImmunoTech Reported Cash, Cash Equivalent...
Benzinga Newsdesk
Earnings Scheduled For April 2, 2024
Benzinga Insights
Monday, April 01, 2024
Preview: AIM ImmunoTech's Earnings
Benzinga Insights
Tuesday, March 26, 2024
Earnings Scheduled For March 26, 2024
Benzinga Insights
Monday, March 25, 2024
AIM ImmunoTech Announces Publication Of Findi...
Benzinga Newsdesk
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying
Avi Kapoor
Thursday, March 07, 2024
AIM ImmunoTech Launches CEO Corner Platform
Benzinga Newsdesk
Wednesday, February 14, 2024
AIM ImmunoTech Announces First Subject Dosed ...
Benzinga Newsdesk
Monday, February 12, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
